Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Interim Management Statement

17 Jan 2008 07:00

Diploma PLC17 January 2008 12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX TELEPHONE: +44 (0)20 7549 5700 FACSIMILE: +44 (0)20 7549 5715 FOR IMMEDIATE RELEASE 17 January 2008 DIPLOMA PLC INTERIM MANAGEMENT STATEMENT Diploma PLC, the international group of specialised distribution businesses is today issuing its first Interim Management Statement in accordance with the Disclosure and Transparency Rules, issued by the UK Listing Authority, in advance of the Company's AGM to be held today at 12.00 midday. This Statement relates to the period from 1 October 2007 to 31 December 2007 and includes the first quarter's trading. The Board is pleased to report that trading in the first quarter has continued to be positive in each of the Group's core business sectors. The contributions from the three acquisitions completed in August last year have been in line with our expectations and as a result, revenue has increased by over 20% on the comparable period last year. In Life Sciences, the businesses in Europe and Canada have shown steady progress, with the newly acquired AMT business in Canada making a substantial contribution to sales and operating profit. Sales in the Seals businesses have increased on the comparable period last year, despite the uncertain economic background in North America. There have been strong export led performances from the US and UK businesses and the M Seals business in Denmark has made a good contribution in its first full quarter in the Group. The Controls businesses, largely based in Europe, continue to benefit from the specific characteristics of the specialised markets in which they operate. In the UK, sales have increased strongly, reflecting both underlying growth and a good contribution from the newly acquired Cabletec business. In Germany, sales activity remains solid against a strong 2006 comparative when Filcon's connector deliveries peaked on certain major projects. The volatility in the foreign exchange markets continues to impact the Group on translation of the results of the overseas businesses to UK sterling. During the first quarter of the financial year the US$ was 5% weaker, relative to UK sterling, than the comparable period last year. Offsetting this, the C$ and the Euro were 10% and 6% stronger, respectively and therefore the net impact on sales and operating profit from these changes in exchange rates was not significant. The Group's financial position continues to be strong with net cash of £11.0m at 31 December 2007 and undrawn committed term facilities of £20.0m. Pursuant to the Sale and Purchase Agreement for the acquisition of Somagen Diagnostics Inc, dated 15 July 2004, the Group will acquire a further 11.2% of the outstanding shares in Somagen Diagnostics Inc from the minority shareholders for consideration of £3.7m, following the exercise of put/call options, agreed at the time of acquisition in July 2004. On completion of this transaction later this month, the Group's shareholding in Somagen Diagnostics Inc will increase from 80% to 91.2%. There have been no other significant changes in the position of the Group in the period since the publication of the Annual Report for the year ended 30 September 2007. At this stage, the Board believes it is making good progress towards achieving its expectations for the full year. Notes: This Interim Management Statement, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Certain statements made in this Statement are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks. The next update on trading is expected to be issued as part of the Half Year results for the six months ending 31 March 2008, which are expected to be released on 12 May 2008. A copy of this Statement, together with further information about Diploma, may be viewed on its website at www.diplomaplc.com For further enquiries please contact: Bruce Thompson, Chief Executive Officer 020 7549 5700 Nigel Lingwood, Group Finance Director 020 7549 5705 Ian Seaton, Bankside Consultants 020 7367 8891 NOTE TO EDITORS: Diploma PLC is an international group of specialised distribution businesses operating in three sectors: Life Sciences - suppliers of consumables, instrumentation and related services for research, environmental and clinical applications. Principal companies are Anachem and the a1-envirosciences group in Europe and Somagen and AMT in Canada. Seals - Suppliers of hydraulic seals, kits and components for heavy mobile machinery and industrial applications. Principal companies are the Hercules Fluid Power Group in North America and FPE and M Seals in Europe. Controls - Suppliers of specialised wiring, connectors and control devices for technically demanding applications. Principal companies are the IS-Group in the UK and US, Sommer Filcon in Germany and Hawco in the UK. Within each of these sectors, the Diploma businesses serve industry segments with long term growth potential and with the opportunity for sustainable superior margins through the quality of customer service, depth of technical support and value adding activities. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.